XWELHealthcare · Diagnostics & ResearchXWEL Stock Forecast: XWELL, Inc. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 47 of 100 as at 1 Aug 2026 — in the lower half.
XWEL stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores XWELL, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (93): Smaller than most of the companies we track.
Value (10): The shares cost a lot relative to the profits and assets behind them.
The rank is the raw material. Whether the rules would actually own XWELL, Inc. — and when they’d sell — is the membership.
XWEL stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on XWEL, reported as data — targets and ratings, the market's view beside the model's.
We don’t hold enough price history for this company yet.
Of the 9 most recent actions, 1 moved their price target up and 2 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 17 Nov 2023 | HC Wainwright & Co. | Maintains | Buy | $1.00 → $7.00 |
| 25 Aug 2023 | HC Wainwright & Co. | Reiterates | Buy | $1.00 |
| 16 May 2023 | HC Wainwright & Co. | Reiterates | Buy | $1.00 |
| 18 Apr 2023 | HC Wainwright & Co. | Reiterates | Buy | $1.00 |
| 4 Apr 2023 | HC Wainwright & Co. | Maintains | Buy | $1.50 → $1.00 |
| 16 Nov 2022 | HC Wainwright & Co. | Maintains | Buy | $2.00 → $1.50 |
| 18 May 2022 | HC Wainwright & Co. | Maintains | Buy | — |
| 17 Nov 2021 | HC Wainwright & Co. | Maintains | Buy | — |
| 16 Feb 2021 | HC Wainwright & Co. | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
XWEL analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
XWELL, Inc. (XWEL) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- −0.2×
- Price / sales
- 0.3×
- Price / book
- 0.7×
- EV / EBITDA
- −0.9×
Cheaper than 77% of US stocks
Cheaper than 90% of US stocks
Cheaper than 80% of US stocks
Cheaper than 67% of US stocks
- Revenue growth (YoY)
- −5.5%
- Earnings growth (YoY)
- −5.5%
- Gross margin
- 35.4%
- Operating margin
- −81.6%
- Net margin
- −81.4%
Higher than 20% of US stocks
Higher than 30% of US stocks
Higher than 45% of US stocks
Higher than 15% of US stocks
Higher than 7% of US stocks
- Return on equity
- −333.7%
- Return on assets
- −29.1%
- Dividend yield
- —
Higher than 4% of US stocks
Higher than 14% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
XWEL vs competitors
The nearest names by industry and size, scored by the same model — like for like.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. XWEL appears on the weeks it earns a place.
Frequently asked questions about XWEL stock
How does Ticker Nerd's model rank XWEL?
As at 1 Aug 2026, XWELL, Inc. ranks 47 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (93 of 100).
What is the XWEL stock forecast for 2030?
No analyst covering XWELL, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for XWEL are extrapolating price history, which says nothing about the business.
What does XWELL, Inc. do?
Xwell Inc. is a health and wellness holding company that operates premium spa and wellness services primarily at airport locations across the United States and internationally.
About XWELL, Inc.
Xwell Inc. is a health and wellness holding company that operates premium spa and wellness services primarily at airport locations across the United States and internationally. The company functions through four main business segments: XpresSpa, which provides travelers with massage, nail care, and skincare services along with spa and travel products; XpresTest, which offers COVID-19 diagnostic testing and screening services through partnership with the CDC; Naples Wax Center, featuring face and body waxing alongside skincare and cosmetic products; and Treat, a travel health and wellness brand delivering in-airport spa experiences. Xwell serves the traveling public and airport employees through physical stores and kiosks, as well as online channels. The company caters to consumers seeking wellness and relaxation services while in transit, positioning itself as a convenient provider of premium health and beauty services in airport environments. Headquartered in New York, Xwell operates in the healthcare and diagnostics sectors.
CEO Mr. Ezra T. Ernst · 175 employees · United States · https://www.xwell.com